West Pharmaceutical Services, Inc. (WST)
390.30
-6.39
(-1.61%)
USD |
NYSE |
Nov 20, 16:00
392.00
+1.70
(+0.44%)
After-Hours: 20:00
West Pharmaceutical Services Research and Development Expense (TTM) : 75.60M for Sept. 30, 2026
Research and Development Expense (TTM) Chart
Historical Research and Development Expense (TTM) Data
| Date | Value |
|---|---|
| September 30, 2026 | 75.60M |
| June 30, 2026 | 74.40M |
| March 31, 2026 | 73.80M |
| December 31, 2025 | 74.30M |
| September 30, 2025 | 71.00M |
| June 30, 2025 | 69.40M |
| March 31, 2025 | 67.80M |
| December 31, 2024 | 69.10M |
| September 30, 2024 | 69.00M |
| June 30, 2024 | 69.90M |
| March 31, 2024 | 68.90M |
| December 31, 2023 | 68.40M |
| September 30, 2023 | 65.90M |
| June 30, 2023 | 63.10M |
| March 31, 2023 | 61.00M |
| December 31, 2022 | 58.50M |
| September 30, 2022 | 56.30M |
| June 30, 2022 | 55.80M |
| March 31, 2022 | 55.20M |
| December 31, 2021 | 52.80M |
| September 30, 2021 | 52.00M |
| June 30, 2021 | 51.40M |
| March 31, 2021 | 48.40M |
| December 31, 2020 | 46.90M |
| September 30, 2020 | 44.20M |
| Date | Value |
|---|---|
| June 30, 2020 | 41.00M |
| March 31, 2020 | 39.80M |
| December 31, 2019 | 38.90M |
| September 30, 2019 | 38.50M |
| June 30, 2019 | 39.30M |
| March 31, 2019 | 40.50M |
| December 31, 2018 | 40.30M |
| September 30, 2018 | 40.20M |
| June 30, 2018 | 39.20M |
| March 31, 2018 | 38.40M |
| December 31, 2017 | 39.10M |
| September 30, 2017 | 39.00M |
| June 30, 2017 | 38.90M |
| March 31, 2017 | 37.70M |
| December 31, 2016 | 36.80M |
| September 30, 2016 | 37.20M |
| June 30, 2016 | 36.70M |
| March 31, 2016 | 36.00M |
| December 31, 2015 | 34.10M |
| September 30, 2015 | 31.90M |
| June 30, 2015 | 33.00M |
| March 31, 2015 | 34.80M |
| December 31, 2014 | 37.30M |
| September 30, 2014 | 39.20M |
| June 30, 2014 | 39.20M |
R&D Expense Definition
R&D expense is a line item from many companies' income statements.
Research and Development Expense (TTM) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Research and Development Expense (TTM) Benchmarks
| Globus Medical, Inc. | 143.52M |
| Glaukos Corp. | 187.19M |
| The Cooper Cos., Inc. | 169.80M |
| Intuitive Surgical, Inc. | 1.493B |
| Becton, Dickinson & Co. | 1.059B |